# Lower Limb Sclerotherapy of Reticular Veins and Telangiectasias

> **NCT05860439** · — · COMPLETED · sponsor: **UPECLIN HC FM Botucatu Unesp** · enrollment: 191 (actual)

## Conditions studied

- Telangiectasis

## Interventions

- **PROCEDURE:** Polidocanol 0,2% + Hypertonic Glucose 70% (PDHG)

## Key facts

- **NCT ID:** NCT05860439
- **Lead sponsor:** UPECLIN HC FM Botucatu Unesp
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2017-01-01
- **Primary completion:** 2023-05-01
- **Final completion:** 2023-06-01
- **Target enrollment:** 191 (ACTUAL)
- **Last updated:** 2023-10-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05860439

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05860439, "Lower Limb Sclerotherapy of Reticular Veins and Telangiectasias". Retrieved via AI Analytics 2026-09-27 from https://api.ai-analytics.org/clinical/NCT05860439. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*